CellFit was a European network of excellence (COST Action CA16119).
The CellFit project ended in September 2021.

CellFit sought to translate knowledge in cell control, cell repair and regeneration from the laboratory bench to clinical application. CellFit aimed to highlight the value of ex vivo models for European R&D operations.



How can 3-D cell based models lead to a reduction in animal testing, improve health research and help in the fight against COVID-19?
A COST Conversation with Professor Tiziana Brevini, Chair of COST Action CA16119.